Comments on the article ‘Participation of the Czech population in colorectal cancer screening – trends and current situation’ in light of the National Colorectal Cancer Screening Programme in Slovakia
Marián Bátovský Orcid.org 1, Rudolf Hrčka Orcid.org 2
+ Affiliation
To read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users
Literature
1. Národné centrum zdravotníckych informácií. Zdravotníctvo Slovenskej republiky 2014. Bratislava: Národné centrum zdravotníckych informácií 2016. [online]. Dostupné z: www.nczisk.sk.
2. Moss S, Mathews C, Day T et al. Increased participation in colorectal cancer screening during a pilot of faecal immunochemical test for haemoglobin (FIT) in England. Gut 2015; 64: 453–462. Abstract OC-002.
3. Zorzi M, Fedeli U, Schievano E et al. Impact on colorectal cancer mortality of screening programmmes based on the faecal immunochemical test. Gut 2015; 64 (5): 784–790. doi: 10.1136/gutjnl-2014-307 508.
4. Dušek L, Májek O, Mužík J et al. Epidemiologie a populační screening nádorů tlustého střeva a konečníku v České republice na podkladě nově dostupných dat. Gastroent Hepatol 2015; 69 (6): 509–517. doi: 10.14735/amgh2015509.
5. Vestník Ministerstva zdravotníctva Slovenskej republiky. Odborné usmernenie Ministerstva zdravotníctva Slovenskej republiky pre realizáciu programu skríningu kolorektálneho karcinómu. Vestník MZ SR 2011; 59 (26): 217–239.
6. Hrčka R, Bátovský M, Šutka J et al. Prepilotná štúdia skríningu kolorektálneho karcinómu pomocou i-TOKS na Slovensku. Gastroenterol Prax 2010; 9 (3): 131–135.
7. Hrčka R. Čo by sme mali vedieť skôr, než sa spustí Národný skríning KRK v SR? Lekárske listy – Onkológia 2010; 12: 3–10.
8. Van Roosbroeck S, Hoeck S, Van Hal G. Population-based screnning for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies. Cancer Epidemiol 2012; 36 (5): 317–324. doi: 10.1016/j.canep.2012.04.003.
9. Giorgi Rossi P, Grazzini G, Anti M et al. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy. J Med Screen 2011; 18 (3): 121–127. doi: 10.1258/jms.2011.011009.
10. Tinmouth J, Patel J, Astin PC et al. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBt test to previous nonresponders. Int J Cancer 2015; 136 (6): E697–E703. doi: 10.1002/ijc.29191.
11. Courtier R, Casamitjana M, Macià et al. Participation in a colorectal cancer screening programme. Influence of the method of contacting the target population. Eur J Cancer Prev 2002; 11 (3): 209–213.
12. Ore L, Hagoel L, Lavi I et al. Screening with faecal occult blood test for colorectal cancer: assessment of two methods that attempt to improve compliance. Eur J Cancer Prev 2001; 10 (3): 251–256.
13. Wong MC, Ching JY, Chan VC et al. Informed choice vs no choice in colorectal cancer screening tests. A prospective cohort study in real-life screening practice. Am J Gastroenterol 2014; 109 (7): 1072–1079. doi: 10.1038/ajg.2014. 136.
14. Flight IH, Wilson CJ, Zajac IT et al. Decision support and the effectiveness of web-based delivery and information tailoring for bowel cancer screening: an exploratory study. JMIR Res Protoc 2012; 1 (2): 2–12. doi: 10.2196/resprot.2135.
15. Sequist TD, Zaslavsky AM, Marshall R et al. Patient and physician reminders to promote colorectal cancer screening. A randomized controlled trial. Arch Intern Med 2009; 169 (4): 364–371. doi: 10.1001/archinternmed.2008.564.
16. Arnold M, Sierra MS, Laversanne M et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017; 66 (4): 683–691. doi: 10.1136/ gutjnl-2015-310912.